Evidence map›Paper›PMID 42346787›Full record

ArticleMarine drugs2026

Barettin Suppresses Pancreatic Ductal Adenocarcinoma Proliferation via Topoisomerase IIα Inhibition.

Caleb A Seekins, Monique R Archuleta, Alexandria E Evans, Julia Podgorski, Jerry E Carr, Vishal Kaleeswaran, Kayla B Nguyen, Matthew E Flowers, Christopher Hulme, Todd W Vanderah and 4 more

Abstract read
In one paragraph

Article in Marine drugs, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Caleb A SeekinsDepartment of Pharmacology, College of Medicine, University of Arizona, Tucson, AZ 85724, USA.ORCID 0009-0008-1110-7125
Monique R ArchuletaDepartment of Pharmacology, College of Medicine, University of Arizona, Tucson, AZ 85724, USA.
Alexandria E EvansDepartment of Chemistry and Biochemistry, College of Science, University of Arizona, Tucson, AZ 85724, USA.
Julia PodgorskiDepartment of Pharmacology, College of Medicine, University of Arizona, Tucson, AZ 85724, USA.
Jerry E CarrDepartment of Pharmacology, College of Medicine, University of Arizona, Tucson, AZ 85724, USA.ORCID 0000-0002-8705-0080
Vishal KaleeswaranDepartment of Chemistry and Biochemistry, College of Science, University of Arizona, Tucson, AZ 85724, USA.ORCID 0009-0001-6654-6220
Kayla B NguyenDepartment of Pharmacology, College of Medicine, University of Arizona, Tucson, AZ 85724, USA.ORCID 0009-0005-7406-5004
Matthew E FlowersDepartment of Pharmacology, College of Medicine, University of Arizona, Tucson, AZ 85724, USA.
Christopher HulmeDepartment of Chemistry and Biochemistry, College of Science, University of Arizona, Tucson, AZ 85724, USA.
Todd W VanderahDepartment of Pharmacology, College of Medicine, University of Arizona, Tucson, AZ 85724, USA.
Paco CárdenasPharmacognosy, Department of Medicinal Chemistry, Uppsala University, 752 37 Uppsala, Sweden.ORCID 0000-0003-4045-6718
John M StreicherDepartment of Pharmacology, College of Medicine, University of Arizona, Tucson, AZ 85724, USA.
Nam Y LeeDepartment of Pharmacology, College of Medicine, University of Arizona, Tucson, AZ 85724, USA.ORCID 0000-0002-3730-0774
Christopher CartmellDepartment of Pharmacology, College of Medicine, University of Arizona, Tucson, AZ 85724, USA.ORCID 0000-0002-8722-9187

Funding

American Cancer Society IRG-18-161-40American Society of Pharmacognosy Research Starter GrantArizona Biomedical Research Commission RFGA2024-022-023
6 · The paper itself

Abstract

Pancreatic ductal adenocarcinoma (PDAC) remains a highly lethal malignancy with few therapeutic options. Topoisomerase IIα (TOPO2α) is frequently overexpressed in PDAC and is associated with poor clinical outcomes, yet current TOPO2α-directed therapies are constrained by limited efficacy and toxicity. Barettin, a brominated indole-containing diketopiperazine isolated from the marine sponge

Indexed as

Antineoplastic AgentsCarcinoma, Pancreatic DuctalDiketopiperazinesPancreatic NeoplasmsPoriferaTopoisomerase II InhibitorsAnimalsCell Line, TumorCell ProliferationDNA-Binding ProteinsDNA Topoisomerases, Type IIHumansAntineoplastic AgentsDiketopiperazinesDNA-Binding ProteinsDNA Topoisomerases, Type IITopoisomerase II InhibitorsbarettinDNA gyrasemarine natural productpancreatic ductal adenocarcinoma (PDAC)topoisomerase IIα

Identifiers

PMID42346787
PMCPMC13302744

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.